Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc., a biopharmaceutical entity in the clinical development phase, is focused on pioneering and commercializing innovative therapies for individuals afflicted by hematological and musculoskeletal conditions that currently lack adequate treatment options. Its flagship protein therapeutic, KER-050, is being advanced to address diminished blood cell counts (cytopenias), specifically anemia and thrombocytopenia, in patients diagnosed with myelodysplastic syndromes and myelofibrosis. Furthermore, the company is progressing KER-047, a small molecule designed to combat anemia, which is presently undergoing Phase 1 clinical evaluation. Another small molecule, KER-012, is also in Phase 1 clinical trials for treating ailments characterized by bone degeneration, such as osteoporosis and osteogenesis imperfecta, alongside pulmonary arterial hypertension. Founded in 2015, the firm maintains its principal operations in Lexington, Massachusetts.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Keros Therapeutics, Inc.
NASDAQ:KROSHealthcare · Biotechnology
-2.82%$11.04
AH$11.04+0.00%vs close
Mkt Cap$218.89M
Float18.46M
O/S19.83M
Vol
$ Vol
RVOL
Inst Own93.6%
SI6.2%
Earnings
Dilution
Financials Summary
Revenue$244.06M
Net Income$87.01M
Total Assets$338.02M
Free Cash Flow$105.95M
Debt & Equity
Debt 5%
Equity 95%
Total Debt$16.88M
Total Equity$303.13M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in KROS's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$338.02M
Liabilities$34.89M
Accounts Receivable$6.37M
Accounts Payable$1.97M
Inventory$0
PP&E (Net)$21.14M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $244.06M | $3.55M | $151K | $0 | $20.1M | $0 | $10M | $10M |
| YoY Growth | 6775.0% | 2251.0% | - | - | - | - | 0.0% | - |
| Cost of Revenue | $1.51M | $0 | $0 | $0 | $0 | $605K | $17.35M | $10.11M |
| Gross Profit | $242.55M | $3.55M | $151K | $0 | $20.1M | -$605K | -$7.35M | -$111K |
| Gross Margin | 99.4% | 100.0% | 100.0% | - | 100.0% | - | -73.5% | -1.1% |
| Research and Development | $129.64M | $173.63M | $135.26M | $87.27M | $55.14M | $33.86M | $17.38M | $10.11M |
| Selling, General, and Administrative | $46.85M | $40.75M | $34.83M | $27.52M | $21.33M | $12.19M | $3.18M | $1.58M |
| Other | -$4.56M | $0 | $0 | $0 | $0 | $0 | -$558K | $237K |
| Total Operating Expenses | $171.93M | $214.38M | $170.09M | $114.79M | $76.47M | $46.05M | $20M | $11.32M |
| Operating Income (EBIT) | $70.62M | -$210.83M | -$169.94M | -$114.79M | -$56.37M | -$46.66M | -$10.56M | -$1.69M |
| Operating Margin | 28.9% | -5939.0% | -112543.7% | - | -280.5% | - | -105.6% | -16.9% |
| Interest Expense | $0 | $0 | $0 | $1K | $4K | $6K | $8K | $0 |
| Interest Income | $0 | $0 | $0 | $1K | $0 | $6K | $0 | $6K |
| Other Income (Expense) | $21.27M | $23.78M | $16.95M | $10.11M | -$360K | $1.12M | -$1.77M | $613K |
| Income Before Tax (EBT) | $91.9M | -$187.05M | -$152.99M | -$104.68M | -$56.73M | -$45.53M | -$12.34M | -$1.08M |
| Income Tax Expense | $4.88M | $300K | $0 | $0 | $2.01M | -$172K | $0 | $257K |
| Net Income | $87.01M | -$187.35M | -$152.99M | -$104.68M | -$58.74M | -$45.36M | -$12.34M | -$1.33M |
| Net Income Margin | 35.7% | -5277.5% | -101319.2% | - | -292.3% | - | -123.4% | -13.4% |
| Supplementary Data | ||||||||
| EPS | 2.34 | -5.00 | -5.20 | -4.15 | -2.52 | -2.93 | -1.39 | -0.15 |
| Diluted EPS | 2.30 | -5.00 | -5.20 | -4.15 | -2.52 | -2.93 | -1.39 | -0.15 |
| Weighted Average OS | 37.22M | 37.44M | 29.45M | 25.24M | 23.33M | 15.51M | 8.88M | 8.88M |
| EBITDA | $93.41M | -$185.82M | -$152.18M | -$104M | -$56.35M | -$45.25M | -$11.89M | -$1.17M |
| EBITDA Margin | 38.3% | -5234.5% | -100779.5% | - | -280.4% | - | -118.9% | -11.7% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $287.42M | $559.93M | $331.15M | $279.05M | $230.04M | $265.88M | $7.02M | $23.26M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $287.42M | $559.93M | $331.15M | $279.05M | $230.04M | $265.88M | $7.02M | $23.26M |
| Accounts Receivable | $6.37M | $4.46M | $1.09M | $841K | $18.2M | $216K | $922K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $2.4M | $1.48M | $1M | $276K | $210K | $160K | $819K | $84K |
| Total Current Assets | $315.43M | $588.89M | $347.29M | $285.77M | $251.44M | $267.73M | $8.93M | $25.53M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $21.14M | $23.49M | $19.47M | $17.57M | $2.4M | $1.6M | $1.91M | $1.38M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1.45M | $1.45M | $1.21M | $0 | $0 | $0 | $0 | $501K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $2.06M | $2.05M | $3.44M | $1.41M | $115K | $115K | $0 |
| Total Long-Term Assets | $22.59M | $26.99M | $22.73M | $21.01M | $3.81M | $1.72M | $2.03M | $1.88M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $338.02M | $615.89M | $370.02M | $306.78M | $255.25M | $269.44M | $10.96M | $27.41M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $1.97M | $4.6M | $5.45M | $3.34M | $3.65M | $2.15M | $2.09M | $501K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $50K | $110K | $185K | $43K | $284K |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $10M |
| Other Current Liabilities | $6.09M | $10.55M | $10.38M | $5.56M | $2.58M | $1.73M | $1.02M | $477K |
| Total Current Liabilities | $20.41M | $27.45M | $24.37M | $16.55M | $11.85M | $7.18M | $4.49M | $11.47M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $62K | $5.08M | $2.56M |
| Total Long-Term Liabilities | $14.47M | $16.88M | $13.44M | $12.81M | $231K | $538K | $5.97M | $3.19M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $34.89M | $44.33M | $37.81M | $29.36M | $12.08M | $7.72M | $10.46M | $14.65M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $19.94M | $19.94M |
| Common Stock | $4K | $4K | $3K | $2K | $2K | $2K | $1K | $1K |
| Retained Earnings | -$481.76M | -$568.78M | -$381.43M | -$228.43M | -$123.75M | -$65.01M | -$19.65M | -$7.31M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$246K |
| Other Stockholders' Equity | $784.89M | $1.14B | $713.64M | $505.86M | $366.93M | $326.73M | $20.14M | $20.07M |
| Total Equity | $303.13M | $571.55M | $332.21M | $277.42M | $243.17M | $261.72M | $495K | $12.76M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $338.02M | $615.89M | $370.02M | $306.78M | $255.25M | $269.44M | $10.96M | $27.41M |
| Supplementary Data | ||||||||
| Total Debt | $16.88M | $18.86M | $14.44M | $13.27M | $1.09M | $899K | $1.27M | $788K |
| Net Debt | -$270.53M | -$541.07M | -$316.7M | -$265.78M | -$228.95M | -$264.98M | -$5.75M | -$22.47M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | $87.01M | -$187.35M | -$152.99M | -$104.68M | -$58.74M | -$45.36M | -$12.34M | -$1.33M |
| Depreciation & Amortization | $1.51M | $1.23M | $815K | $674K | $378K | $278K | $438K | $153K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $46K | $0 | $0 | $0 |
| Stock-Based Compensation | $28.7M | $34.87M | $28.76M | $18.68M | $11.72M | $4.1M | $0 | $81K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | -$825K | -$2.6M | -$143K | $18M | -$18M | $922K | -$552K | -$370K |
| Inventory | $0 | $0 | -$4.5M | $0 | $1.04M | -$922K | $0 | $0 |
| Accounts Payable | -$3M | -$249K | $1.61M | -$408K | $1.49M | $61K | $1.31M | -$2K |
| Other Working Capital | -$8.29M | -$8.59M | $384K | -$3.28M | -$597K | $2.21M | -$7.48M | $7.95M |
| Total Working Capital Change | -$12.11M | -$11.44M | -$2.65M | $14.31M | -$16.07M | $2.27M | -$6.72M | $7.95M |
| Other Non-Cash Items | $2.4M | $1.82M | $1.56M | $953K | $520K | $1.82M | $2.62M | $194K |
| Net Cash from Operating | $107.5M | -$160.87M | -$124.51M | -$70.06M | -$62.15M | -$36.89M | -$16M | $7.04M |
| Investing Activities | ||||||||
| Capital Expenditures | -$1.55M | -$1.93M | -$2.46M | -$1.24M | -$1.02M | -$294K | -$271K | -$217K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$1.55M | -$1.93M | -$2.46M | -$1.24M | -$1.02M | -$294K | -$271K | -$217K |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | - | - | - |
| Common Stock Issuance | -$3.47M | $380.13M | $175.82M | $119.58M | $28.17M | $243.2M | $14K | $11.46M |
| Common Stock Repurchases | -$375M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $11.69M | $3.13M | $731K | $379K | -$3.16M | $0 | -$37K |
| Net Cash from Financing | -$378.47M | $391.82M | $178.96M | $120.31M | $28.55M | $296.04M | $14K | $11.46M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $16K | $0 |
| Net Change in Cash | -$272.52M | $229.02M | $51.98M | $49.01M | -$34.62M | $258.86M | -$16.24M | $18.29M |
| Supplementary Data | ||||||||
| Operating Cash Flow | $107.5M | -$160.87M | -$124.51M | -$70.06M | -$62.15M | -$36.89M | -$16M | $7.04M |
| Capital Expenditure | -$1.55M | -$1.93M | -$2.46M | -$1.24M | -$1.02M | -$294K | -$271K | -$217K |
| Free Cash Flow | $105.95M | -$162.8M | -$126.97M | -$71.3M | -$63.17M | -$37.19M | -$16.27M | $6.83M |
| Cash at Beginning | $561.38M | $332.36M | $280.38M | $231.37M | $265.99M | $7.13M | $23.26M | $5.1M |
| Cash at End | $288.86M | $561.38M | $332.36M | $280.38M | $231.37M | $265.99M | $7.02M | $23.39M |